Related references
Note: Only part of the references are listed.Artemisinin and its derivatives in treating protozoan infections beyond malaria
Cecilia Shi Ni Loo et al.
PHARMACOLOGICAL RESEARCH (2017)
The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review
Mahdi Sharif et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
The known and missing links between Toxoplasma gondii and schizophrenia
Hany M. Elsheikha et al.
METABOLIC BRAIN DISEASE (2016)
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis
A. L. Sutterland et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity
Andrew J. Neville et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Could miltefosine be used as a therapy for toxoplasmosis?
Maha M. Eissa et al.
EXPERIMENTAL PARASITOLOGY (2015)
Schizophrenia and Toxoplasma gondii: an undervalued association?
Jaroslav Flegr
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Association between latent toxoplasmosis and clinical course of schizophrenia - continuous course of the disease is characteristic for Toxoplasma gondii-infected patients
Tuncay Celik et al.
FOLIA PARASITOLOGICA (2015)
Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: A cross-sectional study
Guillaume Fond et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute Psychosis
Joel M. Monroe et al.
SCHIZOPHRENIA BULLETIN (2015)
Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate
Guillaume Fond et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Kazuto Oya et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
A THIAZOLE DERIVATIVE OF ARTEMISININ MODERATELY REDUCES TOXOPLASMA GONDII CYST BURDEN IN INFECTED MICE
Tracey L. Schultz et al.
JOURNAL OF PARASITOLOGY (2014)
The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
Hui-Ling Wang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia
D. Holub et al.
ACTA PSYCHIATRICA SCANDINAVICA (2013)
Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis
Jaroslav Flegr
JOURNAL OF EXPERIMENTAL BIOLOGY (2013)
Significant Reduction of Brain Cysts Caused by Toxoplasma gondii after Treatment with Spiramycin Coadministered with Metronidazole in a Mouse Model of Chronic Toxoplasmosis
Wai Kit Chew et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: Voxel-based-morphometry (VBM) study
Jiri Horacek et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Evaluation of Five Antischizophrenic Agents Against Toxoplasma gondii in Human Cell Cultures
David G. Goodwin et al.
JOURNAL OF PARASITOLOGY (2011)
Artemisinin reduces the level of antibodies to gliadin in schizophrenia
Faith Dickerson et al.
SCHIZOPHRENIA RESEARCH (2011)
Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays
Vesna Munic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes
Jitka Lindova et al.
FOLIA PARASITOLOGICA (2010)
Thiazole, Oxadiazole, and Carboxamide Derivatives of Artemisinin are Highly Selective and Potent Inhibitors of Toxoplasma gondii
Christopher P. Hencken et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Teshome Shibre et al.
SCHIZOPHRENIA BULLETIN (2010)
Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model
Ildiko R. Dunay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
Georgios Pappas et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2009)
A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii
Faith B. Dickerson et al.
SCHIZOPHRENIA RESEARCH (2009)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
Yuko Fujita et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Antibodies to infectious agents in individuals at ultra-high risk for psychosis
G. Paul Amminger et al.
BIOLOGICAL PSYCHIATRY (2007)
Gender differences in behavioural changes induced by latent toxoplasmosis
Jitka Lindova et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2006)
Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia
H. -L. Wang et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Parasites as causative agents of human affective disorders?: The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour
JP Webster et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin
M Sugie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii
L Jones-Brando et al.
SCHIZOPHRENIA RESEARCH (2003)
Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii
O Djurkovic-Djakovic et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Sex-associated hormones and immunity to protozoan parasites
CW Roberts et al.
CLINICAL MICROBIOLOGY REVIEWS (2001)
Share Paper
